NBC SECURITIES, INC.
Broker-DealerPosition in NVCT — Nuvectis Pharma, Inc.
CIK 791540
BIRMINGHAM, AL
Position in NVCT
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$110,340
+$87,150 QoQ
Shares Held
6,000
+100.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#52
of 82 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NBC SECURITIES, INC. holds $5,576,049 across 55 Biotechnology names. NVCT ranks #15 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
10,414 | $815,103 | |
| 2 | TWST |
Twist Bioscience Corp
|
4,512 | $464,194 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
1,623 | $397,261 | |
| 4 | TSHA |
Taysha Gene Therapies, Inc.
|
55,022 | $374,699 | |
| 5 | INBX |
Inhibrx Biosciences, Inc.
|
3,900 | $369,525 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
2,545 | $311,966 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
2,591 | $303,328 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
435 | $271,239 |
All Filings in NVCT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $110,340 | 6,000 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $23,190 | 3,000 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $22,650 | 3,000 | Shares | Sole | 2026-01-29 | |
| 2024-12-31 | $27 | 5 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1 | 300 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1 | 300 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $1 | 100 | Shares | Sole | 2024-04-05 | |
| No filing history on record for this holder in this stock. | ||||||